These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2012-002450-24 Randomized double-blind placebo-controlled prospective, parallel, single centre clinical trial of bacterial vaccine (BACTEK ®) sublingual (oral mucosa) in patients with repeat bronchospasm for the i... 2017-05-24 due-trials
Ongoing, reported early 2012-003253-28 Randomized double-blind placebo-controlled prospective, parallel, multicentre clinical trial of bacterial polivalent vaccine (BACTEK ®)administered by sublingual mucosa in subjects with chronic obst... not-yet-due
Other 2013-001838-17 A MULTICENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP PLACEBO-CONTROLLED CLINICAL STUDY FOR THE ASSESSMENT OF THE IMMUNOMODULATORY EFFICACY, SAFETY AND CLINICAL IMPACT AFTER THREE AND S... not-yet-due
Reported results 2013-005368-24 Extract allergen from Betula verrucosa. Test sensitivity and specificity of diagnostic in prick test preparation. Extracto alergénico de Betula verrucosa. Ensayo de la sensibilidad y de la especifi... 2016-09-05 due-trials
Reported results 2013-005394-45 Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen extract. Determination of the allergenic potency in vivo histamine equivalent units (HEP) Extracto alergénico de Dermatophagoid... 2018-08-07 due-trials
Ongoing 2014-005471-88 Double blind, placebo-controlled, dose finding, prospective, multicenter clinical trial for the treatment of rhinitis/rinoconjuntivitis against grass pollen allergy Ensayo clínico prospectivo multi... not-yet-due
Ongoing, reported early 2015-000820-27 Double blind, placebo-controlled, dose finding, prospective, multicenter clinical trial for the treatment of rhinitis/rinoconjuntivitis against a mixture of Dermatophagoides pteronyssinus and Dermatop... not-yet-due
Completed, but no date 2018-002522-23 A prospective, randomized, double-blind placebo-controlled dose-finding study of different regimens of mannan-conjugated allergoids of birch pollen allergens administered subcutaneously to patients wi... bad-data
Completed, but no date Terminated 2018-003715-22 Prospective, randomized, placebo-controlled, multi-center trial comparing the efficacy and safety of subcutaneous immunotherapy with a mixture of grasses and mites at adequate doses versus monotherapy... bad-data
Ongoing 2018-004262-34 Randomized, placebo-controlled, prospective clinical trial of efficacy and safety for the treatment of rhinitis/rhinoconjunctivitis and asthma against a mixture of Dermatophagoides pteronyssinus and D... not-yet-due
Ongoing 2019-002811-25 Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjuncti... not-yet-due
Ongoing 2019-002865-37 A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis With or Without Mi... not-yet-due
Not reported 2020-004126-32 A prospective open follow-up study with 10 000 mTU/mL mannan-conjugated birch pollen allergoids administered subcutaneously to participants of the T502-SIT-020 trial Eine prospektive offene Folge-S... 2023-06-06 due-trials
Ongoing 2020-005388-30 Quercus ilex and Quercus robur allergenic extracts. Determination of the in vivo allergenic potency in histamine equivalent units (HEP). Extracto alergénico de Quercus ilex y Quercus robur. Determi... not-yet-due
Ongoing 2020-005389-32 Juniperus oxycedrus and Cupressus arizonica allergen extracts. Determination of the in vivo allergenic potency in histamine equivalent units (HEP). Extracto alergénico de Juniperus oxycedrus y Cupr... not-yet-due
Not reported 2021-002252-36 A prospective, randomized, double-blind placebo-controlled multicentre study with 10 000 mTU/mL mannan-conjugated birch pollen allergoids administered subcutaneously to patients with birch pollen-indu... 2022-06-13 due-trials
Not reported Terminated 2021-003014-39 Prospective, randomised, double-blind, double-dummy, placebo-controlled multicenter clinical trial of efficacy and safety with immunotherapy in patients with controlled mild to moderate allergic asthm... 2023-05-09 due-trials
Not reported 2022-004082-20 An open phase III follow-up study in patients previously treated with mannan-conjugated birch pollen allergoids or placebo in the T502-045 trial. Eine offene Phase-III-Folgestudie bei Patienten, di... 2023-05-30 due-trials